RA CAPITAL MANAGEMENT L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...25, 26, 27, 28, 29, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:39 pm
Purchase
2020-12-3113GAtea Pharmaceuticals, Inc.
AVIR
RA CAPITAL MANAGEMENT L.P.5,368,451
6.500%
5,368,451increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GCuris, Inc.
CRIS
RA CAPITAL MANAGEMENT L.P.385,390
8.500%
385,390increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GConcert Pharmaceuticals, Inc.
CNCE
RA CAPITAL MANAGEMENT L.P.1,823,520
5.900%
1,823,520increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GX4 Pharmaceuticals, Inc.
XFOR
RA CAPITAL MANAGEMENT L.P.58,267
9.900%
3,318increase
(+6.04%)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GAscendis Pharma A/S
ASND
RA CAPITAL MANAGEMENT L.P.5,865,338
10.900%
46,476increase
(+0.80%)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GBCTG Acquisition Corp.
BCTG
RA CAPITAL MANAGEMENT L.P.1,250,000
5.800%
1,250,000increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GDyne Therapeutics, Inc.
DYN
RA CAPITAL MANAGEMENT L.P.2,805,045
6.200%
2,805,045increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GAdverum Biotechnologies, Inc.
ADVM
RA CAPITAL MANAGEMENT L.P.950,238
9.700%
950,238increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GFrazier Lifesciences Acquisition Corporation
FLAC
RA CAPITAL MANAGEMENT L.P.1,000,000
7.000%
1,000,000increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GGeron Corporation
GERN
RA CAPITAL MANAGEMENT L.P.31,114,941
9.990%
31,114,941increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GHelix Acquisition Corp.
HLXA
RA CAPITAL MANAGEMENT L.P.700,000
5.900%
700,000increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GImmunoGen, Inc.
IMGN
RA CAPITAL MANAGEMENT L.P.18,417,458
9.800%
18,417,458increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GFIVE PRIME THERAPEUTICS INC
FPRX
RA CAPITAL MANAGEMENT L.P.4,285,161
9.800%
4,285,161increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GInhibrx Biosciences, Inc.
INBX
RA CAPITAL MANAGEMENT L.P.2,129,003
5.600%
2,129,003increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GKinnate Biopharma Inc.
KNTE
RA CAPITAL MANAGEMENT L.P.3,593,052
8.300%
3,593,052increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GInozyme Pharma, Inc.
INZY
RA CAPITAL MANAGEMENT L.P.2,003,653
8.600%
2,003,653increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GLarimar Therapeutics, Inc.
LRMR
RA CAPITAL MANAGEMENT L.P.1,515,151
9.900%
1,515,151increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GAkouos, Inc.
AKUS
RA CAPITAL MANAGEMENT L.P.2,281,249
6.600%
2,281,249increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GLyra Therapeutics, Inc.
LYRA
RA CAPITAL MANAGEMENT L.P.16,317
6.300%
16,317increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-3113GMacroGenics, Inc.
MGNX
RA CAPITAL MANAGEMENT L.P.4,375,217
7.800%
4,375,217increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...25, 26, 27, 28, 29, Next